ESG

A Texas firm opens a plant for a non-toxic chemical that boosts oil output and could turn old wells into a new source of critical minerals.

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.

A new study reveals why GLP-1 drugs work for some and not others. 23andMe's research could personalize obesity treatment for millions of patients.

Motorcoach leader Prevost announces a major expansion of its service centers, aiming to reduce downtime and set new industry standards for customer support.

The award-winning Texas vodka is scaling up with a new million-case distillery. Can it maintain its craft soul while aiming for market dominance?

Tekton Research launches its first multi-specialty clinical trial hub in San Antonio, leveraging top physician expertise to tackle diabetes and obesity.

Progressive Grocer’s annual awards name 68 top products, revealing key trends in sustainability, wellness, and global flavors shaping our grocery carts.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

From commercial fleets to combat readiness, Xos targets the defense sector with its grid-independent mobile charging platform for military operations.

After years of development, Solar Roadways is deploying its new SR5 panel at a military base and seeking investment to scale its intelligent pavement.

Acclaro Medical's new AuraLux laser combines 'cold ablative' tech with a unique business partnership, aiming to make advanced skin treatments safe for all.

Leto Tech's new platform digitizes the caseworker's binder, aiming to streamline resource referrals and address the 80% of health determined by social needs.

With new President Vik Shah and SVP Kevin Hoban, North America's top truck body maker eyes innovation and efficiency amid profound industry shifts.

Celebrating a decade of challenging norms, AESARA eyes its next chapter in global health, armed with AI, RWE, and a focus on complex diseases.

Aspen Snowmass launches its 2026/27 pass lineup with new Flex and Weekday options, enhanced Premier benefits, and expanded military and local discounts.

Rune Labs launches StrivePD Guardian, an AI companion using Anthropic's Claude and a massive dataset to offer 24/7 personalized support for patients.

KingstronBio's successful implant of its advanced ProStyle M® heart valve kicks off a key study, signaling a new era for patients and China's medtech.

With its future riding on a pivotal trial for avexitide, Amylyx's upcoming conference presentation offers a crucial look into its post-ALS strategy.

Miotal plans a Nasdaq debut via a SPAC merger, offering investors a unique play on critical materials, but questions about its vast inventory remain.

A new VC-backed program is giving elite female athletes the tailored health tools sports science has long ignored, aiming to optimize performance and longevity.